Comparison of reversed-phase, hydrophilic interaction, and porous graphitic carbon chromatography columns for an untargeted toxicometabolomics study in pooled human liver microsomes, rat urine, and rat plasma.


Journal

Metabolomics : Official journal of the Metabolomic Society
ISSN: 1573-3890
Titre abrégé: Metabolomics
Pays: United States
ID NLM: 101274889

Informations de publication

Date de publication:
30 Apr 2024
Historique:
received: 12 10 2023
accepted: 20 04 2024
medline: 1 5 2024
pubmed: 1 5 2024
entrez: 30 4 2024
Statut: epublish

Résumé

Untargeted metabolomics studies are expected to cover a wide range of compound classes with high chemical diversity and complexity. Thus, optimizing (pre-)analytical parameters such as the analytical liquid chromatography (LC) column is crucial and the selection of the column depends primarily on the study purpose. The current investigation aimed to compare six different analytical columns. First, by comparing the chromatographic resolution of selected compounds. Second, on the outcome of an untargeted toxicometabolomics study using pooled human liver microsomes (pHLM), rat plasma, and rat urine as matrices. Separation and analysis were performed using three different reversed-phase (Phenyl-Hexyl, BEH C All three reversed-phase columns showed a similar performance, whereas the PGC column was superior to both HILIC columns at least for polar compounds. Comparing the size of feature count across all datasets, most features were detected using the Phenyl-Hexyl or sulfobetaine column. Considering the matrices, most significant features were detected in urine and pHLM after using the sulfobetaine and in plasma after using the ammonium-sulfonic acid column. The results underline that the outcome of this untargeted toxicometabolomic study LC-HRMS metabolomic study was highly influenced by the analytical column, with the Phenyl-Hexyl or sulfobetaine column being the most suitable. However, column selection may also depend on the investigated compounds as well as on the investigated matrix.

Identifiants

pubmed: 38689195
doi: 10.1007/s11306-024-02115-0
pii: 10.1007/s11306-024-02115-0
doi:

Substances chimiques

Graphite 7782-42-5

Types de publication

Journal Article Research Support, Non-U.S. Gov't Comparative Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

49

Informations de copyright

© 2024. The Author(s).

Références

Abdalkader, R., Chaleckis, R., Meister, I., Zhang, P., Wheelock, C. E., & Kamei, K. I. (2021). Untargeted LC-MS metabolomics for the analysis of micro-scaled extracellular metabolites from hepatocytes. Analytical Sciences, 37, 1049–1052.
pubmed: 33342928 doi: 10.2116/analsci.20N032
Adusumilli, R., & Mallick, P. (2017). Data conversion with ProteoWizard msConvert. Methods in Molecular Biology, 1550, 339–368.
pubmed: 28188540 doi: 10.1007/978-1-4939-6747-6_23
Agin, A., Heintz, D., Ruhland, E., Chao de la Barca, J. M., Zumsteg, J., Moal, V., Gauchez, A. S., & Namer, I. J. (2016). Metabolomics—an overview. From basic principles to potential biomarkers (part 1). Médecine Nucléaire, 40, 4–10.
doi: 10.1016/j.mednuc.2015.12.006
Asha, S., & Vidyavathi, M. (2010). Role of human liver microsomes in in vitro metabolism of drugs-a review. Applied Biochemistry and Biotechnology, 160, 1699–1722.
pubmed: 19582595 doi: 10.1007/s12010-009-8689-6
Bapiro, T. E., Richards, F. M., & Jodrell, D. I. (2016). Understanding the complexity of porous graphitic carbon (pgc) chromatography: Modulation of mobile-stationary phase interactions overcomes loss of retention and reduces variability. Analytical Chemistry, 88, 6190–6194.
pubmed: 27228284 pmcid: 5362737 doi: 10.1021/acs.analchem.6b01167
Barnes, S., Benton, H. P., Casazza, K., Cooper, S. J., Cui, X., Du, X., Engler, J., Kabarowski, J. H., Li, S., Pathmasiri, W., Prasain, J. K., Renfrow, M. B., & Tiwari, H. K. (2016a). Training in metabolomics research. I. Designing the experiment, collecting and extracting samples and generating metabolomics data. Journal of Mass Spectrometry, 51, 461–475.
pubmed: 27434804 doi: 10.1002/jms.3782
Barnes, S., Benton, H. P., Casazza, K., Cooper, S. J., Cui, X., Du, X., Engler, J., Kabarowski, J. H., Li, S., Pathmasiri, W., Prasain, J. K., Renfrow, M. B., & Tiwari, H. K. (2016b). Training in metabolomics research. II. Processing and statistical analysis of metabolomics data, metabolite identification, pathway analysis, applications of metabolomics and its future. Journal of Mass Spectrometry, 51, 535–548.
pubmed: 28239968 doi: 10.1002/jms.3780
Bouatra, S., Aziat, F., Mandal, R., Guo, A. C., Wilson, M. R., Knox, C., Bjorndahl, T. C., Krishnamurthy, R., Saleem, F., Liu, P., Dame, Z. T., Poelzer, J., Huynh, J., Yallou, F. S., Psychogios, N., Dong, E., Bogumil, R., Roehring, C., & Wishart, D. S. (2013). The human urine metabolome. PLoS ONE, 8, e73076.
pubmed: 24023812 pmcid: 3762851 doi: 10.1371/journal.pone.0073076
Broadhurst, D. I., & Kell, D. B. (2006). Statistical strategies for avoiding false discoveries in metabolomics and related experiments. Metabolomics, 2, 171–196.
doi: 10.1007/s11306-006-0037-z
Coleman, J., Wrzosek, T., Roman, R., Peterson, J., & McAllister, P. (2001). Setting system suitability criteria for detectability in high-performance liquid chromatography methods using signal-to-noise ratio statistical tolerance intervals. Journal of Chromatography A, 917, 23–27.
pubmed: 11403474 doi: 10.1016/S0021-9673(01)00669-0
Criscuolo, A., Zeller, M., Cook, K., Angelidou, G., & Fedorova, M. (2019). Rational selection of reverse phase columns for high throughput LC-MS lipidomics. Chemistry and Physics of Lipids, 221, 120–127.
pubmed: 30940444 doi: 10.1016/j.chemphyslip.2019.03.006
Diamantidou, D., Sampsonidis, I., Liapikos, T., Gika, H., & Theodoridis, G. (2023). Liquid chromatography-mass spectrometry metabolite library for metabolomics: Evaluating column suitability using a scoring approach. Journal of Chromatography A, 1690, 463779.
pubmed: 36681007 doi: 10.1016/j.chroma.2023.463779
Elmsjo, A., Haglof, J., Engskog, M. K. R., Erngren, I., Nestor, M., Arvidsson, T., & Pettersson, C. (2018). Method selectivity evaluation using the co-feature ratio in LC/MS metabolomics: Comparison of HILIC stationary phase performance for the analysis of plasma, urine and cell extracts. Journal of Chromatography A, 1568, 49–56.
pubmed: 29789170 doi: 10.1016/j.chroma.2018.05.007
Gika, H. G., Theodoridis, G. A., & Wilson, I. D. (2008). Hydrophilic interaction and reversed-phase ultra-performance liquid chromatography TOF-MS for metabonomic analysis of Zucker rat urine. Journal of Separation Science, 31, 1598–1608.
pubmed: 18461568 doi: 10.1002/jssc.200700644
Gilar, M., Daly, A. E., Kele, M., Neue, U. D., & Gebler, J. C. (2004). Implications of column peak capacity on the separation of complex peptide mixtures in single- and two-dimensional high-performance liquid chromatography. Journal of Chromatography A, 1061, 183–192.
pubmed: 15641361 doi: 10.1016/j.chroma.2004.10.092
Hanai, T. (2003). Separation of polar compounds using carbon columns. Journal of Chromatography A, 989, 183–196.
pubmed: 12650251 doi: 10.1016/S0021-9673(02)02017-4
Harrieder, E. M., Kretschmer, F., Bocker, S., & Witting, M. (2022). Current state-of-the-art of separation methods used in LC-MS based metabolomics and lipidomics. Journal of Chromatography. b, Analytical Technologies in the Biomedical and Life Sciences, 1188, 123069.
pubmed: 34879285 doi: 10.1016/j.jchromb.2021.123069
Hemmer, S., Manier, S. K., Fischmann, S., Westphal, F., Wagmann, L., & Meyer, M. R. (2020). Comparison of three untargeted data processing workflows for evaluating LC-HRMS metabolomics data. Metabolites, 10, 378.
pubmed: 32967365 pmcid: 7570355 doi: 10.3390/metabo10090378
Hemmer, S., Wagmann, L., & Meyer, M. R. (2021). Altered metabolic pathways elucidated via untargeted in vivo toxicometabolomics in rat urine and plasma samples collected after controlled application of a human equivalent amphetamine dose. Archives of Toxicology, 95, 3223–3234.
pubmed: 34414480 pmcid: 8448701 doi: 10.1007/s00204-021-03135-8
Hemmer, S., Wagmann, L., Pulver, B., Westphal, F., & Meyer, M. R. (2022). In vitro and in vivo toxicometabolomics of the synthetic cathinone PCYP studied by means of LC-HRMS/MS. Metabolites, 12, 1209.
pubmed: 36557246 pmcid: 9783153 doi: 10.3390/metabo12121209
Imbert, A., Rompais, M., Selloum, M., Castelli, F., Mouton-Barbosa, E., Brandolini-Bunlon, M., Chu-Van, E., Joly, C., Hirschler, A., Roger, P., Burger, T., Leblanc, S., Sorg, T., Ouzia, S., Vandenbrouck, Y., Medigue, C., Junot, C., Ferro, M., Pujos-Guillot, E., … Thevenot, E. A. (2021). ProMetIS, deep phenotyping of mouse models by combined proteomics and metabolomics analysis. Sci Data, 8, 311.
pubmed: 34862403 pmcid: 8642540 doi: 10.1038/s41597-021-01095-3
Khamis, M. M., Adamko, D. J., & El-Aneed, A. (2017). Mass spectrometric based approaches in urine metabolomics and biomarker discovery. Mass Spectrometry Reviews, 36, 115–134.
pubmed: 25881008 doi: 10.1002/mas.21455
Knox, J. H., Unger, K. K., & Mueller, H. (2006). Prospects for carbon as packing material in high-performance liquid chromatography. Journal of Liquid Chromatography, 6, 1–36.
doi: 10.1080/01483918308067647
Kuhl, C., Tautenhahn, R., Bottcher, C., Larson, T. R., & Neumann, S. (2012). CAMERA: An integrated strategy for compound spectra extraction and annotation of liquid chromatography/mass spectrometry data sets. Analytical Chemistry, 84, 283–289.
pubmed: 22111785 doi: 10.1021/ac202450g
Liu, H., Zhu, J., Li, Q., Wang, D., Wan, K., Yuan, Z., Zhang, J., Zou, L., He, X., & Miao, J. (2021). Untargeted metabolomic analysis of urine samples for diagnosis of inherited metabolic disorders. Functional & Integrative Genomics, 21, 645–653.
doi: 10.1007/s10142-021-00804-w
Liu, X., & Locasale, J. W. (2017). Metabolomics: A primer. Trends in Biochemical Sciences, 42, 274–284.
pubmed: 28196646 pmcid: 5376220 doi: 10.1016/j.tibs.2017.01.004
Mahieu, N. G., Huang, X., Chen, Y. J., & Patti, G. J. (2014). Credentialing features: A platform to benchmark and optimize untargeted metabolomic methods. Analytical Chemistry, 86, 9583–9589.
pubmed: 25160088 pmcid: 4188275 doi: 10.1021/ac503092d
Manier, S. K., Keller, A., & Meyer, M. R. (2019a). Automated optimization of XCMS parameters for improved peak picking of liquid chromatography-mass spectrometry data using the coefficient of variation and parameter sweeping for untargeted metabolomics. Drug Testing and Analysis, 11, 752–761.
pubmed: 30479047 doi: 10.1002/dta.2552
Manier, S. K., Keller, A., Schaper, J., & Meyer, M. R. (2019b). Untargeted metabolomics by high resolution mass spectrometry coupled to normal and reversed phase liquid chromatography as a tool to study the in vitro biotransformation of new psychoactive substances. Science and Reports, 9, 2741.
doi: 10.1038/s41598-019-39235-w
Manier, S. K., & Meyer, M. R. (2020). Impact of the used solvent on the reconstitution efficiency of evaporated biosamples for untargeted metabolomics studies. Metabolomics, 16, 34.
pubmed: 32124055 pmcid: 7052028 doi: 10.1007/s11306-019-1631-1
Manier, S. K., Schwermer, F., Wagmann, L., Eckstein, N., & Meyer, M. R. (2020a). Liquid chromatography-high-resolution mass spectrometry-based in vitro toxicometabolomics of the synthetic cathinones 4-MPD and 4-MEAP in pooled human liver microsomes. Metabolites, 11, 3.
pubmed: 33374857 pmcid: 7824391 doi: 10.3390/metabo11010003
Manier, S. K., Wagmann, L., Flockerzi, V., & Meyer, M. R. (2020b). Toxicometabolomics of the new psychoactive substances alpha-PBP and alpha-PEP studied in HepaRG cell incubates by means of untargeted metabolomics revealed unexpected amino acid adducts. Archives of Toxicology, 94, 2047–2059.
pubmed: 32313995 pmcid: 7303098 doi: 10.1007/s00204-020-02742-1
Merck (2019) Care & Use Guide for 2.7 μm SupelTM Carbon LC Column.
Merck (2020) Application Note: LC-MS/MS Analysis of 20 Underivatized Amino Acids on Supel Carbon LC column.
Michely, J. A., & Maurer, H. H. (2018). A multi-analyte approach to help in assessing the severity of acute poisonings—Development and validation of a fast LC-MS/MS quantification approach for 45 drugs and their relevant metabolites with one-point calibration. Drug Testing and Analysis, 10, 164–176.
pubmed: 28777878 doi: 10.1002/dta.2257
Naz, S., Vallejo, M., Garcia, A., & Barbas, C. (2014). Method validation strategies involved in non-targeted metabolomics. Journal of Chromatography A, 1353, 99–105.
pubmed: 24811151 doi: 10.1016/j.chroma.2014.04.071
Neue, U. D. (2005). Theory of peak capacity in gradient elution. Journal of Chromatography A, 1079, 153–161.
pubmed: 16038301 doi: 10.1016/j.chroma.2005.03.008
Pereira, L. (2010). Porous graphitic carbon as a stationary phase in HPLC: Theory and applications. Journal of Liquid Chromatography & Related Technologies, 31, 1687–1731.
doi: 10.1080/10826070802126429
Psychogios, N., Hau, D. D., Peng, J., Guo, A. C., Mandal, R., Bouatra, S., Sinelnikov, I., Krishnamurthy, R., Eisner, R., Gautam, B., Young, N., Xia, J., Knox, C., Dong, E., Huang, P., Hollander, Z., Pedersen, T. L., Smith, S. R., Bamforth, F., … Wishart, D. S. (2011). The human serum metabolome. PLoS ONE, 6, e16957.
pubmed: 21359215 pmcid: 3040193 doi: 10.1371/journal.pone.0016957
Richter, L. H. J., Flockerzi, V., Maurer, H. H., & Meyer, M. R. (2017). Pooled human liver preparations, HepaRG, or HepG2 cell lines for metabolism studies of new psychoactive substances? A study using MDMA, MDBD, butylone, MDPPP, MDPV, MDPB, 5-MAPB, and 5-API as examples. Journal of Pharmaceutical and Biomedical Analysis, 143, 32–42.
pubmed: 28601767 doi: 10.1016/j.jpba.2017.05.028
Si-Hung, L., Causon, T. J., & Hann, S. (2017). Comparison of fully wettable RPLC stationary phases for LC-MS-based cellular metabolomics. Electrophoresis, 38, 2287–2295.
pubmed: 28691762 doi: 10.1002/elps.201700157
Smith, C. A., Want, E. J., O’Maille, G., Abagyan, R., & Siuzdak, G. (2006). XCMS: Processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Analytical Chemistry, 78, 779–787.
pubmed: 16448051 doi: 10.1021/ac051437y
Sonnenberg, R. A., Naz, S., Cougnaud, L., & Vuckovic, D. (2019). Comparison of underivatized silica and zwitterionic sulfobetaine hydrophilic interaction liquid chromatography stationary phases for global metabolomics of human plasma. Journal of Chromatography A, 1608, 460419.
pubmed: 31439439 doi: 10.1016/j.chroma.2019.460419
Steuer, A. E., Kaelin, D., Boxler, M. I., Eisenbeiss, L., Holze, F., Vizeli, P., Czerwinska, J., Dargan, P. I., Abbate, V., Liechti, M. E., & Kraemer, T. (2020). Comparative untargeted metabolomics analysis of the psychostimulants 3,4-methylenedioxy-methamphetamine (MDMA), amphetamine, and the novel psychoactive substance mephedrone after controlled drug administration to humans. Metabolites, 10, 306.
pubmed: 32726975 pmcid: 7465486 doi: 10.3390/metabo10080306
Team, R.C. R (2013) A Language and Environment for Statistical Computing, R Foundation for Statistical Computing.
Thevenot, E. A., Roux, A., Xu, Y., Ezan, E., & Junot, C. (2015). Analysis of the human adult urinary metabolome variations with age, body mass index, and gender by implementing a comprehensive workflow for univariate and OPLS statistical analyses. Journal of Proteome Research, 14, 3322–3335.
pubmed: 26088811 doi: 10.1021/acs.jproteome.5b00354
Tobin, N. H., Murphy, A., Li, F., Brummel, S. S., Taha, T. E., Saidi, F., Owor, M., Violari, A., Moodley, D., Chi, B., Goodman, K. D., Koos, B., & Aldrovandi, G. M. (2021). Comparison of dried blood spot and plasma sampling for untargeted metabolomics. Metabolomics, 17, 62.
pubmed: 34164733 pmcid: 8340475 doi: 10.1007/s11306-021-01813-3
Trivedi, D., Jones, H., Shah, A., & Iles, R. (2012). Development of zwitterionic hydrophilic liquid chromatography (ZIC®HILIC-MS) metabolomics method for shotgun analysis of human urine. Journal of Chromatography & Separation Techniques. https://doi.org/10.4172/2157-7064.1000144
doi: 10.4172/2157-7064.1000144
van de Velde, B., Guillarme, D., & Kohler, I. (2020). Supercritical fluid chromatography—Mass spectrometry in metabolomics: Past, present, and future perspectives. Journal of Chromatography. b, Analytical Technologies in the Biomedical and Life Sciences, 1161, 122444.
pubmed: 33246285 doi: 10.1016/j.jchromb.2020.122444
van der Maaten, L. (2014). Accelerating t-SNE using tree-based algorithms. Journal of Machine Learning Research, 15, 3221–3245.
van der Maaten, L., & Hinton, G. (2008). Visualizing data using t-SNE. Journal of Machine Learning Research, 9, 2579–2605.
Wagmann, L., Jacobs, C. M., & Meyer, M. R. (2022). New psychoactive substances: Which biological matrix is the best for clinical toxicology screening? Ther Drug Monit., 44, 599–605.
pubmed: 35175247 doi: 10.1097/FTD.0000000000000974
Wang, X., Stoll, D. R., Schellinger, A. P., & Carr, P. W. (2006). Peak capacity optimization of peptide separations in reversed-phase gradient elution chromatography: Fixed column format. Analytical Chemistry, 78, 3406–3416.
pubmed: 16689544 pmcid: 2638764 doi: 10.1021/ac0600149
Wehrens, R., Hageman, J. A., van Eeuwijk, F., Kooke, R., Flood, P. J., Wijnker, E., Keurentjes, J. J., Lommen, A., van Eekelen, H. D., Hall, R. D., Mumm, R., & de Vos, R. C. (2016). Improved batch correction in untargeted MS-based metabolomics. Metabolomics, 12, 88.
pubmed: 27073351 pmcid: 4796354 doi: 10.1007/s11306-016-1015-8
Wernisch, S., & Pennathur, S. (2016). Evaluation of coverage, retention patterns, and selectivity of seven liquid chromatographic methods for metabolomics. Analytical and Bioanalytical Chemistry, 408, 6079–6091.
pubmed: 27370688 pmcid: 4983217 doi: 10.1007/s00216-016-9716-4
Yao, L., Sheflin, A. M., Broeckling, C. D., & Prenni, J. E. (2019). Data processing for GC-MS- and LC-MS-based untargeted metabolomics. Methods in Molecular Biology, 1978, 287–299.
pubmed: 31119670 doi: 10.1007/978-1-4939-9236-2_18
Zhao, H., Liu, Y., Li, Z., Song, Y., Cai, X., Liu, Y., Zhang, T., Yang, L., Li, L., Gao, S., Li, Y., & Yu, C. (2018). Identification of essential hypertension biomarkers in human urine by non-targeted metabolomics based on UPLC-Q-TOF/MS. Clinica Chimica Acta, 486, 192–198.
doi: 10.1016/j.cca.2018.08.006

Auteurs

Selina Hemmer (S)

Department of Experimental and Clinical Toxicology, Institute of Experimental and Clinical Pharmacology and Toxicology, Center for Molecular Signaling (PZMS), Saarland University, Homburg, Germany.

Sascha K Manier (SK)

Department of Experimental and Clinical Toxicology, Institute of Experimental and Clinical Pharmacology and Toxicology, Center for Molecular Signaling (PZMS), Saarland University, Homburg, Germany.

Lea Wagmann (L)

Department of Experimental and Clinical Toxicology, Institute of Experimental and Clinical Pharmacology and Toxicology, Center for Molecular Signaling (PZMS), Saarland University, Homburg, Germany.

Markus R Meyer (MR)

Department of Experimental and Clinical Toxicology, Institute of Experimental and Clinical Pharmacology and Toxicology, Center for Molecular Signaling (PZMS), Saarland University, Homburg, Germany. markus.meyer@uks.eu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH